TD Asset Management »

Immix Biopharma shares owned by TD Asset Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $485k 53k 9.11

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Cibc Cad (CM)
Broadcom (AVGO)
Agnico (AEM)
Canadian Natural Resources (CNQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Suncor Energy (SU)
Amazon (AMZN)

View all positions for TD Asset Management

Top funds holding Immix Biopharma

Henderson Group
Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Capital Management
Millennium Management
Adage Capital Partners GP
Logos Global Management
Vanguard Group
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
BlackRock
Geode Capital Management

View all funds holding Immix Biopharma